Chemotherapy Devices Market - Industry Insights, Size, Trends, and Forecast to 2026

Chemotherapy Devices Market - Industry Insights, Size, Trends, and Forecast to 2026

Chemotherapy is administrated intravenously and is majorly conducted in hospital. It involves administration of medicine through a tube in a vein. Intravenous medications are given directly into the blood stream through a variety of methods. A venous access device (VAD) is a surgically implanted device that provides long-term access to a major vein. The two most commonly used VAD for cancer treatment are catheter and implanted ports. Intravenous (IV) administration of therapy medication allows for rapid entry into the body's circulation, where it is carried throughout the body in the blood stream. IV methods also enable more flexibility with drug dosing.

Market Dynamics

Increasing incidences of different cancers worldwide is the major factor driving chemotherapy devices market growth. According to the World Health Organization (WHO), 2017, nearly 1 in 6 deaths occur due to cancer globally and around 70% of deaths from cancer occur in low- and middle-income economies. According to Breast Cancer Organization, in 2017, approximately 252,710 new cases of breast cancer were identified in the U.S., of which 63,410 cases were of non-invasive breast cancer.

Moreover, increasing government and private funding coupled with rising disposable income is also projected to drive chemotherapy devices market growth. According to the National Cancer Institute 2016 report, an estimated national expenditures for cancer care in the U.S. in 2017, were US$ 147.3 billion. Costs are likely to increase over the forecast period, as the population ages and cancer prevalence increases. However, not all chemotherapy patient requires a venous access device. For some chemotherapy treatment plans, the inconvenience of implanting and accessing a VAD can outweigh the benefits.

Key features of the study:

This report provides in-depth analysis of the chemotherapy devices market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global chemotherapy devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Advanced Chemotherapy Technologies, Baxter International, Becton, Dickinson Company, B. Braun, Fresenius Kabi, Halyard Health, ICU Medical, Moog Inc., Micrel Medical, Smiths Group, Terumo Corporation, and Zyno Medical
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global chemotherapy devices market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for chemotherapy devices market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:

Global Chemotherapy Devices Market, By Product:
Catheter
Non-tunnelled catheters
Tunnelled central catheters
Surgically implantable catheters or ports
Peripherally inserted central catheters (PICC)
Cannula
Pump
Others
Global Chemotherapy Devices Market, By End User:
Hospital
Clinics
Home Care
Global Chemotherapy Devices Market, By Region:
North America
By Country:
U.S.
Canada
By Product:
Catheter
Non-tunnelled catheters
Tunnelled central catheters
Surgically implantable catheters or ports
Peripherally inserted central catheters (PICC)
Cannula
Pump
Others
By End Use:
Hospital
Clinics
Home Care
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Product:
Catheter
Non-tunnelled catheters
Tunnelled central catheters
Surgically implantable catheters or ports
Peripherally inserted central catheters (PICC)
Cannula
Pump
Others
By End Use:
Hospital
Clinics
Home Care
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Product:
Catheter
Non-tunnelled catheters
Tunnelled central catheters
Surgically implantable catheters or ports
Peripherally inserted central catheters (PICC)
Cannula
Pump
Others
By End Use:
Hospital
Clinics
Home Care
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Product:
Catheter
Non-tunnelled catheters
Tunnelled central catheters
Surgically implantable catheters or ports
Peripherally inserted central catheters (PICC)
Cannula
Pump
Others
By End Use:
Hospital
Clinics
Home Care
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Product:
Catheter
Non-tunnelled catheters
Tunnelled central catheters
Surgically implantable catheters or ports
Peripherally inserted central catheters (PICC)
Cannula
Pump
Others
By End Use:
Hospital
Clinics
Home Care
Africa
By Country:
South Africa
Central Africa
North Africa
By Product:
Catheter
Non-tunnelled catheters
Tunnelled central catheters
Surgically implantable catheters or ports
Peripherally inserted central catheters (PICC)
Cannula
Pump
Others
By End Use:
Hospital
Clinics
Home Care
Company Profiles
Advanced Chemotherapy Technologies*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Baxter International
Becton, Dickinson Company
Braun
Fresenius Kabi
Halyard Health
ICU Medical
Moog Inc.
Micrel Medical
Smiths Group
Terumo Corporation
Zyno Medical
“*” marked represents similar segmentation in other categories in the respective section."